Feasibility of stepwise baricitinib tapering after complete response in alopecia areata: A real-world observational cohort study
Hye Rin Seo, Do-Young Kim · 2026
Read Feasibility of stepwise baricitinib tapering after complete response in alopecia areata: A real-world observational cohort study by Hye Rin Seo, Do-Young Kim (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13487817.txt.
Description
Hye Rin Seo and Do-Young Kim report a 2026 real-world try at slow dose cuts of a hair drug after full regrowth in alopecia areata. The disease makes hair fall out in patches and tends to relapse. Sixty-six patients at a Seoul hospital had held full regrowth on baricitinib at 4 milligrams a day for two months or more. Cuts began from late 2023 to early 2026 on a set step plan.
Steps drop through mixed 4 and 2 milligram days, then 2 milligrams a day. Later steps thin to five days a week, then each other day, then stop. Checks each six to eight weeks gate each next step. Small returns get local care or a held step. Big returns, set by a score of five or more, force a jump back to full dose. That jump is the fail mark for the whole plan.
Catalog record
| CREATOR | Hye Rin Seo, Do-Young Kim |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 8123 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |